Upadacitinib Salvage Therapy for Infliximab experienced patients with Acute Severe Ulcerative Colitis.

Robert Gilmore, Lian Tan,Richard Fernandes,Yoon-Kyo An,Jakob Begun

Journal of Crohn's & colitis（2023）

Cited 0|Views5

No score

Abstract

Upadacitinib may have a role as a safe and effective salvage therapy for steroid-refractory ASUC in patients who have previously failed to respond to infliximab therapy. Prospective studies are required to determine the safety and efficacy of upadacitinib use in this setting before routine use can be recommended.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined